Overall, we predict that frequencies of Mtb-specific effector CD4+ and CD8+ T cells in blood are significantly higher (from 2- to 4- fold) in an active versus a latent Mtb-infected NHP and thus a combination of these cells and various time points post-infection should be targeted as potential biomarkers of Mtb infection progression. This evidence concerns the gene CD4 and infection.